http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20050103158-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb0d9a06f4c98fe19ed3db1ae100d48e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-168 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate | 2005-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c1e20967e899cbf4467f740c0a7cb4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec3dc63c2c4f6cb0c8fda7d6b657be5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebad410d42eef05ee93fde02bd7803d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_756005fd4ae423ae23d12f54fde362d0 |
| publicationDate | 2005-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20050103158-A |
| titleOfInvention | Medicament improving the anti-tumour action of interferon-gamma, and anti-cancer composition comprising interferon-gamma and the medicament |
| abstract | The present invention relates to an anti-cancer effect-improving agent of interferon-gamma and an anti-cancer composition comprising the anti-cancer effect-improving agent and interferon-gamma as an active ingredient, more specifically, phytohemagglutinin and interferon- which are lectins derived from kidney beans. The present invention relates to a pharmaceutical composition for an anticancer agent containing gamma as an active ingredient, wherein the phytohemagglutinin is contained in an interferon-gamma preparation that is frequently used for treating cancer, and thus, even at a low dose without side effects, the anticancer drug is effectively treated with interferon-gamma. To increase the effect, co-formulations with a small amount of interferon-gamma plus 1/30 of interferon-gamma alone have a greater anti-cancer effect than interferon-gamma alone, resulting in an excess of interferon Many side effects from gamma administration can be alleviated and treatment of cancer with interferon-gamma Improved effectiveness and administration of small amounts of interferon-gamma can greatly reduce the medical burden on the patient. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160106952-A |
| priorityDate | 2005-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.